|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:798-805
© 2002 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease (CHD) |
From the Department of Cardiac Surgery and Center for Experimental Surgery and Anesthesiology,a the Department of Pathology,b and the Department of Biostatistics,c Katholieke Universiteit Leuven, Belgium.
Received for publication June 11, 2001. Revisions requested Aug 14, 2001; revisions received Oct 2, 2001. Accepted for publication Oct 8, 2001. Address for reprints: Willem Flameng, MD, CEHA, Provisorium I, Minderbroedersstraat 17, 3000 Leuven, Belgium (E-mail: willem.flameng{at}med.kuleuven.ac.be).
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Xenograft valves have been used when no homografts were available in a number of instances. Typically, a Dacron polyester fabric graft with a stented porcine bioprosthesis has been chosen,
1 but stentless aortic or pulmonary xenografts
4-7 have also been used, with mixed results.
Experimentally, we used a young sheep model with valve implantation in the pulmonary position to test several potentially suitable xenografts in right ventricular outflow tract reconstruction.
8-10 An attractive conduit for its off-the-shelf availability and sizing is a valved segment of fixed bovine jugular vein. Few studies have analyzed the performance of this valved conduit. Ichikawa and coworkers
11 described excellent results in adult dogs after 1 year of implantation with bovine jugular vein graft segments with trileaflet valves fixed with a hydrophilic polyepoxy compound. Bonhoeffer and associates
12 used specially made glutaraldehyde-fixed bovine jugular vein segments sutured in a stent for percutaneous implantation of a valve in pulmonary position in lambs. One of 7 successfully implanted valves showed calcification after 2 months, and 1 valve showed limited degeneration. No reports are available concerning the fate of this type of valved conduit in a standard juvenile sheep experimental model used for durability testing.
In this study we examined the degeneration characteristics of bovine valved jugular vein conduits conventionally fixed with glutaraldehyde (Contegra model 220; VenPro Corporation, Irvine, Calif) after 20 weeks of implantation in growing sheep younger than 6 months and compared them with those of a commercially available Dacron polyester fabric conduit with a bioprosthetic Hancock valve included (MH100, Medtronic, Inc, Minneapolis, Minn). This type of valved bovine jugular vein conduit has recently been introduced in Europe for clinical trials.
13
| Materials and methods |
|---|
|
|
|---|
Valves studied
Seven bovine valved jugular vein conduits (Contegra model 220) were obtained from the manufacturer, and three Medtronic Hancock Model 100 Valved Conduits (MH100) were obtained from the manufacturer. The conduits were stored and handled as prescribed by the manufacturer.
Implantation
Valves were implanted by previously described methods.
8 After premedication with ketamine, anesthesia was induced and maintained with halothane and nitrous oxide. Fentanyl was administered in bolus doses as necessary. Mechanical ventilation was instituted, and a left thoracotomy was performed in the second intercostal space. After intravenous administration of 3 mg/kg heparin, a pneumatic right ventricular assist system (Medos-HIA VAD; Medos-Helmholtz Institute, Aachen, Germany) was installed with the inflow cannula in the right atrium and the outflow cannula 1 cm before the pulmonary bifurcation. After transection of the pulmonary artery, the conduits were interposed with continuous 4-0 Prolene sutures (Ethicon, Inc, Somerville, NJ) for both proximal and distal anastomoses. Afterward the native pulmonary valve was destroyed by tearing two cusps with a clamp introduced through a purse-string suture placed at the sinuses. The chest was closed with a drain in the left pleural space. The animal was extubated immediately and brought to the recovery room. Feeding was allowed immediately. Intravenous fluid administration was stopped after 2 hours. The chest drain was removed after 6 hours.
The animals received analgesia (piritramide) for the first 2 days according to regular schemes and received diuretics as necessary. A long-acting penicillin preparation and enoxaparine, 20 mg twice daily, were administered for 6 days. Afterward the sheep were returned to the controlled animal facility, where their general health was checked daily.
Explantation and analysis
Explantation was performed 20 weeks after implantation. After anesthesia, the thoracotomy was reopened and epicardial echocardiography was performed. Afterward 3 mg/kg heparin was administered, and the valve was excised together with proximal and distal parts of the sheep pulmonary artery.
Gross examination
Valves were grossly inspected from the inflow and outflow sides. Afterward the valve was longitudinally transected through the commissures. Each of the three specimens thus included prevalvular and postvalvular parts of the sheep pulmonary artery, together with a part of the bovine jugular vein wall (or Dacron polyester fabric with stent and porcine aortic wall, in the case of the MH100) and a cusp.
X-ray assessment
X-ray examination in two directions was performed under mammographic conditions to demonstrate and localize macroscopic calcifications.
Histologic examination
For histologic examination, a longitudinal transection of the specimen through the middle of a cusp was embedded in paraffin. Sections 4 µm thick were routinely stained with hematoxylin and eosin, Masson trichrome stain for collagen, an elastic Von Giesson stain, a phosphotungstic acid-hematoxylin stain for fibrin, and Von Kossa calcium staining.
Electron microscopy
For transmission electron microscopy, a cusp was divided into three parts, and the wall was divided in its inflow and outflow parts. From each of the five parts 3 to 10 samples (<1 mm in diameter) were embedded in Epon (Resolution Performance Products, Houston, Tex). Samples were taken serially, covering the entire thickness of the part. Sections 1 µm thick were stained with toluidine blue and examined by light microscopy. Ultrathin sections were cut and stained with uranyl acetate and lead citrate. Sections were treated with 2% potassium pyroantimonate to demonstrate calcium. Grids were examined in a Philips CM10 transmission electron microscope (FEI Company Electron Optics, Eindhoven, The Netherlands). Random photographs were taken.
Quantitative calcium determination
Half of each segment was used for quantitative calcium determination. The cusps were divided into three parts: commissural area, basal part, and free edge. The wall was divided into two parts: inflow side and outflow part. Inflow and outflow parts of the wall were defined as the parts of the wall below and above the cusp. After lyophilization, the tissue was pulverized and desiccated to constant weight in an oven. Pulverized tissue was diluted in 20% hydrochloric acid at a ratio of 10 mg dried tissue per 1 mL hydrochloric acid. Calcium content was measured by flame atomic absorption spectrometry and expressed in micrograms per milligram of dry weight. All three cusps of every valve were analyzed, and the mean calcium content was calculated for each of the five parts with the three segments of a single valve. This mean was used for statistical analysis.
Data management and statistical analysis
Data are expressed as medians with ranges. A Mann-Whitney U test was performed on calcium content data for each of the five described parts of the conduits, with valve type as independent factor and calcium content as dependent factor. Statistical analysis was performed with STATISTICA 4.5 (StatSoft Inc, Tulsa, Okla).
| Results |
|---|
|
|
|---|
Preexplantation epicardial echocardiography (Figure 1)
|
Severe turbulence over the valve was present in 2 MH100 conduits, and laminar flow was present in only 1. Only 6 of 9 cusps were moving. Regurgitation was present in all valves (1+, 2+, and 4+). Coaptation height was always less than 2 mm.
Macroscopic findings (Figure 2)
|
In all three MH100 valves fibrous sheathing was extensive, completely encapsulating two of nine cusps and partially retracting two other cusps, with slight fibrous overgrowth of the remaining five cusps. In 2 valves there was evident lack of coaptation. The leaflets were deformed and retracted. The base of five cusps was clearly hardened, showing signs of calcification. One commissure between two cusps was fused, with a calcific nodule present. The aortic wall parts of the Hancock valves were severely calcified.
X-ray examination (Figure 3)
|
Severe calcification of the aortic wall portion of the MH100 conduits was always present. Calcification of the commissures was omnipresent, and slight calcification of the basal portions was seen in 6 of 9 leaflets.
Histologic examination (Figure 4)
|
MH100
A fibrous sheath covered the inside of the inflow and outflow portions of the MH100, first covering the Dacron polyester fabric tube and closer to the valve the aortic wall portion of the Hancock valve. This sheath was thicker on the outflow portion than on the inflow portion. This thick, fibrous sheath covered considerable parts of the leaflets, causing attraction of the leaflets to the wall. The global architecture of the valve cusps was distorted in 2 valves, with thickening of the fibrosa and distortion of the three layers. Calcification was severe in the aortic wall portion of the Hancock valve, mainly in the elastin-rich area of the outflow part but also in the inflow part. Calcification was present at the base of the leaflet in 2 valves.
Transmission electron microscopy
The leaflets of the Contegra conduits consisted of a well-preserved, wavy collagen pattern without signs of calcium deposition. The ultrastructure of the Hancock valves within the MH100 conduits was similar to the findings that we published previously elsewhere.
14
Quantitative calcium determination
The calcium content was less in the walls of the Contegra conduits than in the walls of the MH100 conduits. Furthermore, the base and commissure of the cusps were also less calcified in the Contegra conduits than in the MH100 conduits (Table 1).
|
| Discussion |
|---|
|
|
|---|
Previously we were able to demonstrate slight to moderate calcification of the cusps together with more extensive calcification of the aortic wall of the Toronto SPV (St Jude Medical Inc, Minneapolis, Minn) and Biocor No-React II stentless aortic xenografts (BioCor, LLC, Belohorizonte, Brazil) implanted in the pulmonary position in young sheep.
10 Although the cusps of Freestyle (Medtronic) valves remained pliable, the aortic wall portion had already calcified extensively after 3 months of implantation in this juvenile sheep model.
8 In a growing pig model, Schoof and colleagues
16 showed even worse results with the Freestyle valve, with massive thickening of the cusps and valve dysfunction. In our sheep model, commercially available pericardial stentless conduits (Pericarbon; Sorin BioMedica, Saluggia, Italy) exhibited severe calcification and fibrous overgrowth of the cusps and conduit wall.
8 The results of the Contegra conduit presented here are clearly superior to our earlier experimental observations of aortic or pericardial stentless xenografts.
As with every xenograft and allograft available, calcification occurred in the Contegra conduits. The amount of calcium deposition, however, was lower than that in the control valves. Anticalcification treatment might further decrease the calcification in these valves. It is remarkable that the conduit wall calcified more extensively than the cusps, a fact also seen in porcine aortic xenografts. Anticalcification treatment with amino-oleic acid does not seem to reduce calcification in aortic wall portions.
8 So far, no reports have been published about the effects of anticalcification treatments on the jugular vein walls.
Comparison of these results of the Contegra conduit with those of other valve types in our model should be performed with caution, because the other valve types (except for the MH100 control group) were explanted after 3 or 6 months of implantation. The very large coaptation area between the cusps of the Contegra relative to all other implanted valve types is nonetheless a striking finding. This is caused by the difference in anatomy of the valve cusps, with the jugular vein valve cusps having on transection a horizontal part closing the orifice of the jugular vein and this horizontal part continuing with a relatively sharp angle in a vertical part responsible almost completely for the large coaptation. A second contributing factor is the lack of fibrous overgrowth on the leaflets, which caused retraction and leakage in all other valve types, including the Hancock valve in the MH100.
We chose the MH100 conduit as a control preparation because it is a commercially available conduit with right ventricular outflow tract reconstruction as its primary indication. As stated previously, allografts are still the gold standard for this indication, and in clinical practice the Contegra conduit should be used in the absence of suitable allografts as an alternative to currently available bioprosthetic conduits, including the MH100. Only when medium-term and long-term durability in clinical practice has been demonstrated might the Contegra conduit be indicated as an alternative to allografts in routine practice.
A word of caution should also be expressed about generalization of our results to reconstructions in patients with pulmonary hypertension or abnormalities in pulmonary artery anatomy that would cause distortion of the conduit. The conduit was implanted in our model as a straight tube in the pulmonary artery in sheep without pulmonary hypertension, so the hemodynamic and anatomic conditions were optimal for avoidance of pulmonary regurgitation. It is unlikely that optimal conditions can be reached in all clinical cases.
The incidence of endocarditis in our series was not surprising, because it has to be kept in mind that the valves were implanted in the pulmonary position with multiple perioperative and postoperative injections given and with surgical wounds that were difficult to cover adequately in a sterile way in awake sheep that rubbed the cage often. Endocarditis is encountered in most series of experiments in which valves are implanted in the right-sided position in sheep.
8,16,17 Valves affected by endocarditis were not included in the analysis concerning degeneration and calcification because they showed completely different characteristics of destruction and calcification of the leaflets, as has also been stated by other authors.
16
We conclude that the VenPro Contegra conduit had performance clearly superior to that of the control MH100 when implanted in pulmonary artery position in juvenile sheep for 5 months.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
N. Sekarski, H. van Meir, M. E.B. Rijlaarsdam, P. H. Schoof, D. R. Koolbergen, J. Hruda, L. K. von Segesser, E. J. Meijboom, and M. G. Hazekamp Right Ventricular Outflow Tract Reconstruction With the Bovine Jugular Vein Graft: 5 Years' Experience With 133 Patients Ann. Thorac. Surg., August 1, 2007; 84(2): 599 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sierra, J. T. Christenson, N. H. Lahlaidi, M. Beghetti, and A. Kalangos Right Ventricular Outflow Tract Reconstruction: What Conduit to Use? Homograft or Contegra? Ann. Thorac. Surg., August 1, 2007; 84(2): 606 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Chiappini, C. Barrea, and J. Rubay Right Ventricular Outflow Tract Reconstruction With Contegra Monocuspid Transannular Patch in Tetralogy of Fallot Ann. Thorac. Surg., January 1, 2007; 83(1): 185 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rastan, T. Walther, I. Daehnert, J. Hambsch, F. W. Mohr, J. Janousek, and M. Kostelka Bovine jugular vein conduit for right ventricular outflow tract reconstruction: evaluation of risk factors for mid-term outcome. Ann. Thorac. Surg., October 1, 2006; 82(4): 1308 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L.S. Morales, B. E. Braud, K. S. Gunter, K. E. Carberry, K. A. Arrington, J. S. Heinle, E. D. McKenzie, and C. D. Fraser Jr Encouraging results for the Contegra conduit in the problematic right ventricle-to-pulmonary artery connection. J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O. Shebani, S. McGuirk, M. Baghai, J. Stickley, J. V. De Giovanni, F. A. Bu'Lock, D. J. Barron, and W. J. Brawn Right ventricular outflow tract reconstruction using Contegra(R) valved conduit: natural history and conduit performance under pressure Eur. J. Cardiothorac. Surg., March 1, 2006; 29(3): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gober, P. Berdat, M. Pavlovic, J.-P. Pfammatter, and T. P. Carrel Adverse Mid-Term Outcome Following RVOT Reconstruction Using the Contegra Valved Bovine Jugular Vein Ann. Thorac. Surg., February 1, 2005; 79(2): 625 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Meyns, L. Van Garsse, D. Boshoff, B. Eyskens, L. Mertens, M. Gewillig, S. Fieuws, E. Verbeken, and W. Daenen The Contegra conduit in the right ventricular outflow tract induces supravalvular stenosis J. Thorac. Cardiovasc. Surg., December 1, 2004; 128(6): 834 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Corno, S. D. Qanadli, N. Sekarski, S. Artemisia, M. Hurni, P. Tozzi, and L. K. von Segesser Bovine Valved Xenograft in Pulmonary Position: Medium-Term Follow-Up With Excellent Hemodynamics and Freedom From Calcification Ann. Thorac. Surg., October 1, 2004; 78(4): 1382 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tiete, J. S. Sachweh, U. Roemer, R. Kozlik-Feldmann, B. Reichart, and S. H. Daebritz Right ventricular outflow tract reconstruction with the Contegra bovine jugular vein conduit: a word of caution Ann. Thorac. Surg., June 1, 2004; 77(6): 2151 - 2156. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |